$332.24 0.2%
HCA Stock Price vs. AI Score
Data gathered: November 22

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - HCA Healthcare (HCA)

Analysis generated April 30, 2024. Powered by Chat GPT.

HCA Healthcare is one of the leading healthcare services providers in the United States, operating hospitals, surgery centers, emergency rooms, urgent care centers, and other medical facilities. With its vast network of facilities, HCA Healthcare offers a wide range of health services to a diverse patient population across the country. Given its significant footprint in the American healthcare system, HCA Healthcare plays an essential role in providing care and has a substantial impact on the healthcare market.

Read full AI stock Analysis

Stock Alerts - HCA Healthcare (HCA)

company logo HCA Healthcare | November 19
Insider Alert: Whalen Kathleen M is selling shares
company logo HCA Healthcare | November 15
Insider Alert: Akdamar Erol R is selling shares
company logo HCA Healthcare | November 13
Web Traffic is up by 36.5% over the last month.
company logo HCA Healthcare | November 12
Ro Khanna (member of U.S. congress) is selling shares

About HCA Healthcare

HCA Healthcare, Inc. is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities.


HCA Healthcare
Price $332.24
Target Price Sign up
Volume 2,290,000
Market Cap $84.9B
Year Range $295.94 - $415.54
Dividend Yield 0.79%
PE Ratio 15.04
Analyst Rating 81% buy
Industry Health Care Services

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2417.5B7.97B9.52B1.27B-1.3B5.030
Q2 '2417.5B7.79B9.71B1.46B3.55B5.530
Q1 '2417.3B7.79B9.55B1.59B3.36B5.930
Q4 '2317.3B7.84B9.46B1.61B3.62B5.930
Q3 '2316.2B7.64B8.58B1.08B2.88B3.910

Insider Transactions View All

Akdamar Erol R filed to sell 6,843 shares at $353.
November 14 '24
Billington Phillip G filed to sell 52,702 shares at $350.
November 14 '24
Whalen Kathleen M filed to sell 9,454 shares at $358.
November 18 '24
Cuffe Michael S. filed to sell 29,678 shares at $385.4.
September 12 '24
Whalen Kathleen M filed to sell 9,454 shares at $363.5.
July 31 '24

What is the Market Cap of HCA Healthcare?

The Market Cap of HCA Healthcare is $84.9B.

What is HCA Healthcare's PE Ratio?

As of today, HCA Healthcare's PE (Price to Earnings) ratio is 15.04.

What is the current stock price of HCA Healthcare?

Currently, the price of one share of HCA Healthcare stock is $332.24.

How can I analyze the HCA stock price chart for investment decisions?

The HCA stock price chart above provides a comprehensive visual representation of HCA Healthcare's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling HCA Healthcare shares. Our platform offers an up-to-date HCA stock price chart, along with technical data analysis and alternative data insights.

Does HCA offer dividends to its shareholders?

Yes, HCA Healthcare (HCA) offers dividends to its shareholders, with a dividend yield of 0.79%. This dividend yield represents HCA Healthcare's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering HCA Healthcare in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of HCA Healthcare?

Some of the similar stocks of HCA Healthcare are Abbott Laboratories, Cardinal Health, Henry Schein, Idexx Laboratories, and LabCorp.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.